# Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia

> **NCT00091234** · PHASE2,PHASE3 · UNKNOWN · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC** · enrollment: 279 (estimated)

## Conditions studied

- Leukemia

## Interventions

- **DRUG:** gemtuzumab ozogamicin

## Key facts

- **NCT ID:** NCT00091234
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-06
- **Primary completion:** 2013-12
- **Final completion:** —
- **Target enrollment:** 279 (ESTIMATED)
- **Last updated:** 2012-07-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00091234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00091234, "Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00091234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*